PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+13.91%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$4.54B
AUM Growth
+$4.54B
(+23%)
Cap. Flow
+$487M
Cap. Flow
% of AUM
10.73%
Top 10 Holdings %
Top 10 Hldgs %
50.93%
Holding
89
New
9
Increased
15
Reduced
22
Closed
5
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$216M |
| 2 |
McDonald's
MCD
|
$152M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$148M |
| 4 |
Coca-Cola
KO
|
$94.5M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
$92.4M |
Top Sells
| 1 |
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
|
$96.7M |
| 2 |
Carnival Corp
CCL
|
$82.7M |
| 3 |
KBR
KBR
|
$82.5M |
| 4 |
Intel
INTC
|
$59.4M |
| 5 |
QUNR
Qunar Cayman Islands Limited
QUNR
|
$58M |
Sector Composition
| 1 | Technology | 23.02% |
| 2 | Communication Services | 19.17% |
| 3 | Consumer Discretionary | 18.26% |
| 4 | Industrials | 12.04% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Biogen
BIIB
$19.4B
| $1.99M | 0.04% | 6,500 | – | – |
|
52
Apple
AAPL
$3.45T
| $1.97M | 0.04% | 18,700 +4,000 | +27% | +$421K |
|
53
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.8M | 0.04% | 17,220 -4,000 | -19% | -$419K |
|
|
JUNO
54
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.76M | 0.04% | 40,000 | – | – |
|
|
ALR
55
DELISTED
Alere Inc
ALR
| $1.76M | 0.04% | 44,970 | – | – |
|
56
RTX Corp
RTX
$212B
| $1.73M | 0.04% | 18,000 | – | – |
|
57
Incyte
INCY
$16.5B
| $1.72M | 0.04% | 15,864 -8,000 | -34% | -$867K |
|
58
Pfizer
PFE
$141B
| $1.54M | 0.03% | 47,610 | – | – |
|
|
SGEN
59
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.53M | 0.03% | 34,000 +12,000 | +55% | +$538K |
|
|
BEAT
60
DELISTED
BioTelemetry, Inc.
BEAT
| $1.52M | 0.03% | 130,000 | – | – |
|
61
LivaNova
LIVN
$3.08B
| $1.42M | 0.03% | +23,982 | New | +$1.42M |
|
62
Ironwood Pharmaceuticals
IRWD
$214M
| $1.39M | 0.03% | 120,000 | – | – |
|
63
Gilead Sciences
GILD
$140B
| $1.32M | 0.03% | +13,000 | New | +$1.32M |
|
64
Verastem
VSTM
$569M
| $1.28M | 0.03% | 688,924 -889,989 | -56% | -$1.65M |
|
65
Cardinal Health
CAH
$35.5B
| $1.25M | 0.03% | 14,000 | – | – |
|
66
Groupon
GRPN
$1.06B
| $1.25M | 0.03% | 407,000 | – | – |
|
|
IMGN
67
DELISTED
Immunogen Inc
IMGN
| $1.23M | 0.03% | 90,600 | – | – |
|
68
Johnson & Johnson
JNJ
$427B
| $1.19M | 0.03% | 11,600 | – | – |
|
|
FMI
69
DELISTED
Foundation Medicine, Inc.
FMI
| $1.16M | 0.03% | +55,000 | New | +$1.16M |
|
|
INFI
70
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.15M | 0.03% | 146,932 +39,000 | +36% | +$306K |
|
|
DFS
71
DELISTED
Discover Financial Services
DFS
| $1.07M | 0.02% | 20,000 | – | – |
|
72
Merck
MRK
$210B
| $993K | 0.02% | 18,800 | – | – |
|
|
EMC
73
DELISTED
EMC CORPORATION
EMC
| $975K | 0.02% | 38,000 +5,000 | +15% | +$128K |
|
74
Cimpress
CMPR
$1.55B
| $973K | 0.02% | 12,000 | – | – |
|
75
Owens Corning
OC
$12.6B
| $940K | 0.02% | 20,000 | – | – |
|